Hemasource Inc

FDA Filings

This page includes the latest FDA filings for Hemasource Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)
Registration Number3010611994
FEI Number3010611994
NameSource Products, Ltd.
Owner & OperatorHemaSource, Inc.
Contact Address485 South 5700 West Suite 400
Salt Lake City UT 84104 US
Official Correspondent
  • Tiffany Child
  • 1-801-6561990-x
Registration Status1
Initial ImporterN
Registration Expiration2020-04-25
Registration Address1431 Heck Rd.
Columbiana, OH 44408 US
Establishment TypeRepack or Relabel Medical Device



Registration Number1724809
FEI Number3002996286
NameHEMASOURCE
Owner & OperatorHemaSource, Inc.
Contact Address485 South 5700 West Suite 400
Salt Lake City UT 84104 US
Official Correspondent
  • Tiffany Child
  • 1-801-6561990-x
Registration Status1
Initial ImporterY
Registration Expiration2020-04-25
Registration Address485 South 5700 West Suite 400
Salt Lake City, UT 84104 US



FDA Filings

Device
Company
DeviceDate
Hemasource, Inc.
Tempo 2023-10-18
Hemasource, Inc.
Tempo 2023-10-18
Hemasource, Inc.
Select Choice 2023-05-17
Hemasource, Inc.
Select Choice 2023-05-17
Hemasource, Inc.
Select Choice 2023-05-17
Hemasource, Inc.
Select Choice 2023-05-17
Hemasource, Inc.
Select Choice 2023-05-17
HemaSource, Inc.
Otc Medication2020-06-25
HemaSource, Inc.
SelectChoice Hand Sanitizer2020-04-30

Similar & Related FDA Registered Companies

    Related Finance Registrations
    U.S. Import Records [external site]
    Import IDShipmentCargo DescriptionQuantity
    2020071836570Shanghai ,China (Mainland) -> Oakland, CaliforniaPVP GEL SWABSTICK3120 CTN
    2020070849Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML1008 CAS
    2020070865Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML8064 CAS
    2020070865Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML8064 CAS
    2020070865Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML8064 CAS
    2020070865Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML8064 CAS
    2020070865Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML8064 CAS
    2020070865Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML8064 CAS
    2020070865Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML8064 CAS
    2020070865Anvers,Belgium -> Savannah, GeorgiaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML8064 CAS
    202005156201Anvers,Belgium -> Long Beach, CaliforniaSODIUM CITRATE 4% 250ML PACKED ONTO 22 PALLET S1308 CAS
    202003195811Anvers,Belgium -> Long Beach, CaliforniaSODIUM CITRATE 4% 250ML PACKED ONTO 22 PALLETS1308 CAS
    202002157581Anvers,Belgium -> Long Beach, CaliforniaSODIUM CITRATE 4% 250ML1308 CAS
    202001233787Anvers,Belgium -> Long Beach, CaliforniaSOLUTION SODIUM CITRATE 4% & ANTICOGULANT 250 ML1308 CAS
    202001227464Anvers,Belgium -> Savannah, GeorgiaSODIUM CITRATE 4% 250MLPACKED ONTO 22 PALLETS2616 CAS
    202001227464Anvers,Belgium -> Savannah, GeorgiaSODIUM CITRATE 4% 250MLPACKED ONTO 22 PALLETS2616 CAS

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.